Approximately 40% of adults aged 65 years or older take at least five prescriptions with 20% taking ten or more. The prevalence of drug-drug interactions in older adults has been estimated to be more than 80%. Efficient analysis of pharmacokinetic and pharmacodynamic drug – drug interactions is essential to reduce risk, which leads to adverse drug events (ADEs), hospitalizations, and increased healthcare utilization. Studies repeatedly show that pharmacist intervention decreases medication-related problems and increases patient safety. Nevertheless, risk assessment involving pharmacists who lack the appropriate tools can be time-consuming.
This webinar will review pharmacokinetic and pharmacodynamic concerns with opioids, potential COVID-19 treatment options, and medication use in older adults. Through case examples, it will provide insight into how technology can be leveraged to reduce medication-related problems and improve patient outcomes.
Steven Gilbert, MBA, RPh
Vice President of Quality Improvement
Tabula Rasa Healthcare
Steve Gilbert is currently the Vice-President of Performance Improvement at Tabula Rasa HealthCare (TRHC). Prior to TRHC, he was primarily a hospital practitioner, who occupied management positions with increasing span of control and depth of services. Steve has contributed to the profession during his career with the initiation of innovative pharmacy services, as well as authoring journal manuscripts and book chapters. The New Jersey Pharmacists Association recently named Steve the 2020 Excellence in Innovation Award winner for 2020 based on his work for the profession and patient care. Steve received his BSc in Pharmacy from the Philadelphia College of Pharmacy and Science and his MBA from Saint Joseph’s University in Philadelphia. Steve completed a residency in hospital pharmacy at the Thomas Jefferson University Hospital.
Katie Meyer, PharmD
Pharmacist, Learning & Development
Tabula Rasa Healthcare
Dr. Meyer began her career at Tabula Rasa HealthCare (TRHC) in 2016 as a clinical pharmacist in PACE. She’s since joined TRHC’s corporate University team and is now responsible for clinical education of healthcare professionals, patients and the TRHC team. During her career she has worked in community and hospital settings. Her primary practice has been in long term acute care where she cared for critically ill patients on ventilator support and/or long term intravenous antibiotics. Dr. Meyer received her Doctor of Pharmacy degree in 2008 from the University of the Sciences in Philadelphia. She obtained her Board Certification in Pharmacotherapy in 2014 and Board Certification in Geriatric Pharmacy in 2017.